Diffuse peritoneal leiomyomatosis: An exceptional entity in a male patient

Hajar Khibri; Amal Bousseaden; Badreddine Alami; Saïd Boujraf; Samira Rabhi

doi:10.4103/jcrt.JCRT_688_17

CASE REPORT

Year : 2020 | Volume : 16 | Issue : 8 | Page : 217-222

Diffuse peritoneal leiomyomatosis: An exceptional entity in a male patient

Hajar Khibri¹, Amal Bousseaden², Badreddine Alami³, Saïd Boujraf³, Samira Rabhi⁴
¹ Department of Internal Medicine, Faculty of Medicine and Pharmacy of Rabat, Ibn Sina University Hospital, Mohammed V University, Rabat, Morocco
² Department of Medicine, Mohamed V Regional Hospital, Al Houceima, Morocco
³ Department of Biophysics and Clinical MRI Methods, Faculty of Medicine of Fez, Fez, Morocco
⁴ Department of Internal Medicine, Faculty of Medicine and Pharmacy of Fez, Hassan II University Hospital, University Sidi Mohamed Ben Abdallah, Fez, Morocco

Correspondence Address:
Saïd Boujraf
Department of Biophysics and Clinical MRI Methods, Faculty of Medicine and Pharmacy of Fez, BP. 1893, Km 2.200, Sidi Hrazem Road, Fez 30000
Morocco

Source of Support: None, Conflict of Interest: None

Check

DOI: 10.4103/jcrt.JCRT_688_17

Diffuse peritoneal leiomyomatosis is a benign peritoneal tumor which develops from smoother muscular fibers. It is a rare entity in females undergoing hormonal effects. This pathological entity is exceptional in male patients. Hence, we report a unique case of diffuse peritoneal leiomyomatosis that occurred in a male patient without hormonal stimulations. The etiopathology and genesis are not completely elucidated. Besides, the clinical symptoms are not specific. The positive diagnosis is based on sets of imaging argument. The anatomicopathological studies allow confirming the diagnosis and reject any tumoral origin. The evolution of the pathology is often favorable. The malignant transformation is exceptional. The treatment is based on abolishing any of the hormonal stimulations. The surgical exeresis is indicated in case of higher peritoneal mass. In case of recurrence or progression, luteinizing hormone-releasing hormone analogs or surgical castrations are indicated.

[FULL TEXT] [PDF]*

Table of Contents

Similar in PUBMED

Related articles

Citation Manager

Access Statistics

Reader Comments

Email Alert *

Add to My List *

* Requires registration (Free)

Article Access Statistics
Viewed	1414
Printed	241
Emailed	0
PDF Downloaded	240
Comments	[Add]